Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines

Clinical and Vaccine Immunology

Volumn 18, Issue 10, 2011, Pages 1719-1727

  Harro, Clayton ^a   Chakraborty, Subhra ^a   Feller, Andrea ^a   DeNearing, Barbara ^a   Cage, Alicia ^a   Ram, Malathi ^a   Lundgren, Anna ^b   Svennerholm, Ann Mari ^b   Bourgeois, August L ^c   Walker, Richard I ^c   Sack, David A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIAL VACCINE; BICARBONATE; BUFFER; CERAVACX; CIPROFLOXACIN; COTRIMOXAZOLE; ENTEROTOXIGENIC ESCHERICHIA COLI VACCINE; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ANOREXIA; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BLOATING; CHILL; CLINICAL ARTICLE; COHORT ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DIARRHEA; DIET RESTRICTION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE COMPARISON; DRUG FEVER; DRUG INDUCED HEADACHE; ENTEROTOXIGENIC ESCHERICHIA COLI; FECES ANALYSIS; FECES CULTURE; FEMALE; FLATULENCE; HUMAN; MALAISE; MALE; MYALGIA; NAUSEA; ORAL REHYDRATION THERAPY; PRIORITY JOURNAL; VOMITING;

ANTIBODIES, BACTERIAL; BIOMEDICAL RESEARCH; DIARRHEA; DRUG EVALUATION; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; HUMAN EXPERIMENTATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

EID: 80053437076     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05194-11     Document Type: Article

References (35)

1. Ahren, C. M., and A. M. Svennerholm. 1985. Experimental enterotoxin-induced Escherichia coli diarrhea and protection induced by previous infection with bacteria of the same adhesin or enterotoxin type. Infect. Immun. 50:255-261. (Pubitemid 15239218)
2. Black, R. E., M. M. Levine, M. L. Clements, L. Cisneros, and V. Daya. 1982. Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo. Rev. Infect. Dis. 4:540-545.
3. Clements, M. L., et al. 1981. Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrob. Agents Chemother. 20:104-108. (Pubitemid 11002446)
4. Cohen, M. B., et al. 2002. Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine. Infect. Immun. 70:1965-1970. (Pubitemid 34242197)
5. Coster, T. S., et al. 2007. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infect. Immun. 75:252-259. (Pubitemid 46047900)
6. DuPont, H. L. 1995. Pathogenesis of traveler's diarrhea. Chemotherapy 41(Suppl. 1):33-39.
7. DuPont, H. L., et al. 1971. Pathogenesis of Escherichia coli diarrhea. N. Engl. J. Med. 285:1-9.
8. Evans, D. G., D. J. Evans, Jr., and W. Tjoa. 1977. Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor. Infect. Immun. 18:330-337. (Pubitemid 8232204)
9. Evans, D. G., D. Y. Graham, and D. J. Evans, Jr. 1984. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli. Gastroenterology 87:934-940. (Pubitemid 14040469)
10. Evans, D. G., T. K. Satterwhite, D. J. Evans, Jr., and H. L. DuPont. 1978. Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect. Immun. 19:883-888.
11. Evans, D. J., Jr, D. G. Evans, A. R. Opekun, and D. Y. Graham. 1988. Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2. FEMS Microbiol. Immunol. 1:9-18.
12. Graham, D. Y., M. K. Estes, and L. O. Gentry. 1983. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology 85:1017-1022. (Pubitemid 13007791)
13. Kotloff, K. L., et al. 1995. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 13:1488-1494.
14. Levine, M. M., et al. 1982. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand. J. Infect. Dis. Suppl. 33:83-95. (Pubitemid 13247836)
15. Levine, M. M., et al. 1977. Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect. Immun. 17:78-82. (Pubitemid 8130629)
16. Levine, M. M., et al. 1979. Immunity to enterotoxigenic Escherichia coli. Infect. Immun. 23:729-736. (Pubitemid 9138978)
17. Levine, M. M., et al. 1980. Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact. Am. J. Epidemiol. 111:347-355. (Pubitemid 10184071)
18. McKenzie, R., et al. 2007. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine 25:3684-3691. (Pubitemid 46584755)
19. McKenzie, R., et al. 2008. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC. Vaccine 26:4731-4739.
20. McKenzie, R., et al. 2008. Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. Vaccine 26:3291-3296.
21. Merson, M. H., et al. 1976. Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N. Engl. J. Med. 294:1299-1305.
22. Porter, C. K., et al. 2011. A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC). Vaccine 29:5869-5885.
23. Qadri, F., A. M. Svennerholm, A. S. Faruque, and R. B. Sack. 2005. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18:465-483. (Pubitemid 40995112)
24. Sack, D. A., et al. 1978. Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N. Engl. J. Med. 298:758-763.
25. Sack, D. A., J. C. McLaughlin, R. B. Sack, F. Orskov, and I. Orskov. 1977. Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J. Infect. Dis. 135:275-280. (Pubitemid 8049538)
26. Sack, D. A., et al. 2007. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico. Vaccine 25:4392-4400. (Pubitemid 46691284)
27. Sack, D. A., et al. 1998. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect. Immun. 66:1968-1972. (Pubitemid 28194090)
28. Sack, R. B., et al. 1971. Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J. Infect. Dis. 123:378-385.
29. Sack, R. B., et al. 1975. Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N. Engl. J. Med. 292:1041-1045.
30. Savarino, S. J., et al. 1998. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults. J. Infect. Dis. 177:796-799. (Pubitemid 28099903)
31. Svennerholm, A. M., and J. Tobias. 2008. Vaccines against enterotoxigenic Escherichia coli. Expert Rev. Vaccines 7:795-804.
32. Tacket, C. O., et al. 1992. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am. J. Trop. Med. Hyg. 47:276-283.
33. Tribble, D. R., et al. 2009. Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clin. Infect. Dis. 49:1512-1519.
34. Walker, R. I., D. Steele, and T. Aguado. 2007. Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease. Vaccine 25:2545-2566. (Pubitemid 46400935)
35. World Health Organization. 2006. Future directions for research on enterotoxigenic Escherichia coli vaccines for developing countries. Wkly. Epidemiol. Rec. 81:97-104.